REQUEST A DEMO
Total
USD $0.00
Search more companies

Farpax SIA (Latvia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Farpax SIA Profile Updated: December 24, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2021 Available in: English & Russian Download a sample report

Farpax SIA is an enterprise located in Latvia, with the main office in Marupe. It operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on February 10, 2015. The total number of employees is currently 37 (2020). From the latest financial highlights, Farpax SIA reported a net sales revenue drop of 9.48% in 2021. There was a total negative growth of 30.46% in Farpax SIA’s total assets over the same period.

Headquarters
Dzirnieku iela 26
Marupe; Marupes municipality; Postal Code: 2167

Contact Details: Purchase the Farpax SIA report to view the information.

Basic Information
Total Employees:
Purchase the Farpax SIA report to view the information.
Financial Auditors:
Purchase the Farpax SIA report to view the information.
Incorporation Date:
February 10, 2015
Key Executives
Purchase this report to view the information.
Chairman of the Board of Directors
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Farpax SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-9.48%
Total operating revenue
-8.95%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total Assets
-30.46%
Total Equity
-25.86%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.8%
Cash Ratio
1.47%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?